Housing finance – Katalyst Wealth

[Stock notes] – Repco Home Finance…marking a turnaround?

August 18, 2023

Hello Sir, Hope you are doing well. Remember, in 2017-18, housing finance stocks were all the rage. Repco Home Finance too was quite famous then and was frequently quoted about on various business channels. However, the stock peaked out around Rs 900 in June 2017 and went as low as 90 in May 2020. Since then, the stock has recovered to around current levels of 375 and the business is also showing signs of turnaround. Mr. K Swaminathan took over the…

6th Nov’20 – Sep’20 earnings update on Suven Pharma and Can Fin Homes

November 6, 2020

Dear Members, We have released 6th Nov’20 – Sep’20 earnings update on Suven Pharmaceuticals and Can Fin Homes. For other updates, please refer the following link – https://katalystwealth.com/category/latest-updates/ Date: 6th Nov’20 Suven Pharmaceuticals (NSE – SUVENPHAR) – May’17 Alpha stock CMP – 325.75 (BSE); 326.60 (NSE) Rating – Positive – 5% weightage; this is not an investment advice (refer rating interpretation) Source: bseindia.com Suven Pharmaceuticals got demerged from Suven Lifesciences with the entire revenue generating businesses consisting of CRAMS,…

7th Aug’20 – Jun’20 earnings update on Manappuram and Aarti Drugs

August 7, 2020

Dear Members, We have released 7th Aug’20 – Jun’20 earnings update on Manappuram Finance and Aarti Drugs. The same has been produced below. For other updates, please refer the following link – https://katalystwealth.com/category/latest-updates/ Date: 7th Aug’20 Manappuram Finance (NSE – MANAPPURAM) – Jul’17 Alpha stock CMP – 161.60 (BSE); 161.60 (NSE) Rating – Positive – 8% weightage; this is not an investment advice (refer rating interpretation) Source: bseindia.com Manappuram has reported decent set of numbers for Q1 FY 21; however,…